iRhythm launches initial phases of manufacturing automation plans

iRhythm announced that the company has launched the initial phases of its previously disclosed manufacturing automation plans, marking a significant corporate milestone expected to set the stage for future growth and innovation while also yielding substantial cost savings. In this initial phase, iRhythm has implemented an autohandler machine to automate the testing of printed circuit board assembly, or PCBA, components of the recently-launched Zio monitor. This technology automates the functional testing of PCBAs, handles their movement to and from test fixtures, and separates passed and failed units, streamlining the manufacturing process and enhancing overall efficiency. Zio monitor was previously assembled and tested manually; the introduction of manufacturing automation enhances iRhythm’s scalability for continued expansion in both the U.S. and international markets. Additionally, as the company anticipates that the new Zio monitor will serve as the foundational hardware platform for future technology iterations – including the next generation mobile cardiac telemetry product – automation will be crucial in keeping pace with the projected global demand for its Zio ECG monitoring products. The company anticipates that all phases of planned manufacturing improvements will enable capacity production of up to 10M units annually.